These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 34853284
1. Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes. Kamo T, Kuroda K, Kondo S, Hayashi U, Fudo S, Yoneda T, Takaya A, Nukaga M, Hoshino T. Chem Pharm Bull (Tokyo); 2021; 69(12):1179-1183. PubMed ID: 34853284 [Abstract] [Full Text] [Related]
4. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling. Wang X, Yang Y, Gao Y, Niu X. Int J Mol Sci; 2020 May 18; 21(10):. PubMed ID: 32443639 [Abstract] [Full Text] [Related]
5. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods. Salari-Jazi A, Mahnam K, Sadeghi P, Damavandi MS, Faghri J. Sci Rep; 2021 Jan 27; 11(1):2390. PubMed ID: 33504907 [Abstract] [Full Text] [Related]
6. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose. Kondratieva A, Palica K, Frøhlich C, Hovd RR, Leiros HS, Erdelyi M, Bayer A. Eur J Med Chem; 2024 Feb 15; 266():116140. PubMed ID: 38242072 [Abstract] [Full Text] [Related]
10. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1). Nagulapalli Venkata KC, Ellebrecht M, Tripathi SK. Eur J Med Chem; 2021 Dec 05; 225():113747. PubMed ID: 34391033 [Abstract] [Full Text] [Related]
20. A close look onto structural models and primary ligands of metallo-β-lactamases. Raczynska JE, Shabalin IG, Minor W, Wlodawer A, Jaskolski M. Drug Resist Updat; 2018 Sep 01; 40():1-12. PubMed ID: 30466711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]